Ovarian Masses: Changing Clinico Histopathological Trends

被引：14

作者：

Sharadha S.O. ^{[1
]}

Sridevi T.A. ^{[2
]}

Renukadevi T.K. ^{[2
]}

Gowri R. ^{[2
]}

Binayak D. ^{[2
]}

Indra V. ^{[2
]}

机构：

[1] Department of Obstetrics and Gynecology, ESIC Medical College and PGIMSR, K.K.Nagar, Chennai, 600078, TamilNadu

[2] ESIC Medical College and PGIMSR, Chennai

来源：

The Journal of Obstetrics and Gynecology of India | 2015年 / 65卷 / 1期

关键词：

Changing trends; Mucinous cystadenoma; Ovarian masses;

D O I：

10.1007/s13224-014-0575-7

中图分类号：

学科分类号：

摘要：

Objective: To study the clinical and histopathological presentation of ovarian masses. Method: Retrospective analysis of 205 cases from May 2009 to June 2013. Results: Incidence of ovarian masses was 6.9 %. Among 205 cases, 68 % were neoplastic. Among the neoplasms, 87.8 % were benign, 10 % malignant, and 2.2 % borderline. Mean ages of malignant and benign neoplasm were 41 and 39 years, respectively. 42.9 % malignant tumors presented with non-specific abdominal and constitutional symptoms. Serous cystadenoma was the commonest benign tumor (67 %) followed by Mucinous (19 %) and Dermoid (11.6 %). Most common malignant ovarian tumor was Serous cystadenocarcinoma (42.9 %). Out of the malignant cases, all were primary except one secondary deposit from Non-Hodgkin’s Lymphoma. Only 28.6 % presented at stage I, remaining presented at stage III/IV. Conclusion: Ovarian neoplasms have twice the incidence of non-neoplasms. Mean age of malignant tumors is decreased. Rising trend in Mucinous cystadenoma is noted. © 2014, Federation of Obstetric & Gynecological Societies of India.

引用

页码：34 / 38

页数：4

共 14 条

[1]

Uma Devi K., Current status of gynecological cancer care in India, J Gynecol Oncol., 20, 2, pp. 77-80, (2009)

[2]

Parkin D.M., Bray F., Ferlay J., Et al., Global cancer statistics, 2002, CA Cancer J Clin., 55, 2, pp. 74-108, (2005)

[3]

Murthy N.S., Shalini S., Suman G., Et al., Changing trends in incidence of ovarian cancer- the Indian Scenario, Asian Pac J Cancer Prev., 10, 6, pp. 1025-1030, (2009)

[4]

Yeole B.B., Kumar A.V., Kurkure A., Et al., Population-based survival from cancers of breast, cervix and ovary in women in Mumbai, India, Asian Pac J Cancer Prev., 5, 3, pp. 308-315, (2004)

[5]

Mondal S.K., Banyopadhayay R., Nag D.R., Et al., Histologic pattern, bilaterality and clinical evaluation of 957 ovarian neoplasms: a 10 year study in a tertiary hospital of eastern India, J Cancer Res Ther., 7, 4, pp. 433-437, (2011)

[6]

Wasim T., Majrroh A., Siddiq S., Comparison of clinical presentation of benign and malignant ovarian tumors, J Pak Med Assoc., 59, (2009)

[7]

Ashraf A., Shaikh S., Ishfaq A., Et al., The relative frequency and histopathological pattern of ovarian masses, Biomedica., 28, pp. 98-102, (2013)

[8]

Poole J., Nordin A., Trent cancer registry, Profile of ovarian cancer in England, (2012)

[9]

Rosenblatt K.A., Thomas D.B., Reduced risk of ovarian cancer in women with a tubal ligation or hysterectomy. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives, Cancer Epidemiol Biomark Prev., 5, pp. 933-935, (1996)

[10]

Dutta D.K., Dutta I., Origin of ovarian cancer: molecular profiling, J Obstet Gynecol India., 63, 3, pp. 152-157, (2013)

← 1 2 →